Compare OFIX & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OFIX | LWLG |
|---|---|---|
| Founded | 1987 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 622.1M | 578.6M |
| IPO Year | N/A | N/A |
| Metric | OFIX | LWLG |
|---|---|---|
| Price | $15.15 | $3.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $21.50 | N/A |
| AVG Volume (30 Days) | 190.2K | ★ 1.9M |
| Earning Date | 11-04-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $818,058,000.00 | $100,605.00 |
| Revenue This Year | $3.97 | N/A |
| Revenue Next Year | $5.84 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.31 | N/A |
| 52 Week Low | $10.24 | $0.79 |
| 52 Week High | $20.48 | $6.26 |
| Indicator | OFIX | LWLG |
|---|---|---|
| Relative Strength Index (RSI) | 45.02 | 39.39 |
| Support Level | $14.88 | $3.09 |
| Resistance Level | $16.00 | $3.45 |
| Average True Range (ATR) | 0.45 | 0.22 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 25.82 | 23.94 |
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.